RE:RE:RE:3D Signatures Partnership with KnightI bought into the 3D deal through Haywood. The value to the drug companies is huge in my opinion, it has the potential to save them millions in costs and reduce the time from trial to market by years. obvuously they would be willing to,pay a handsome price for this technology. On the prognostic side 3d's technology enables doctors to know what the best course of action is based on each patients specific situation, which can save insurance companies millions In drug costs as some patients will respond well to less expensive treatments. And for patients it could be he difference between life and death; if your doctor doesn't know how you will respond to different treatment options they may not get you the treatment you need before it's too late, but using 3d's technology and simply taking a blood test you can find out the treatment that is best for your situation in a very short period of time. LDT approval expected within 6 months followed closely by CLIA approval in the US. With the Knight and Goodman stamp of approval and advisory services definitely worth taking a look into for a long term investment. Starts trading this Tuesday under DXD.v.